Home

ego ellenség Építeni ck7 tumor marker riasztás Miniszter fal

I Heart Pathology on X: "Carcinomas generally demonstrate specific staining  patterns based on the epithelial type and differentiation status. CK7 and  CK20 stains may be helpful during the workup of a primary
I Heart Pathology on X: "Carcinomas generally demonstrate specific staining patterns based on the epithelial type and differentiation status. CK7 and CK20 stains may be helpful during the workup of a primary

SEOM—GECOD clinical guideline for unknown primary cancer (2021) | Clinical  and Translational Oncology
SEOM—GECOD clinical guideline for unknown primary cancer (2021) | Clinical and Translational Oncology

Utility of five commonly used immunohistochemical markers TTF‐1, Napsin A,  CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous  cell carcinoma of the lung: a retrospective study of 246 fine
Utility of five commonly used immunohistochemical markers TTF‐1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine

Pathology Outlines - Cytokeratin 7 (CK7, K7)
Pathology Outlines - Cytokeratin 7 (CK7, K7)

Cytokeratin 7 marker validation. Cytokeratin 7 (CK7) demonstrates... |  Download Scientific Diagram
Cytokeratin 7 marker validation. Cytokeratin 7 (CK7) demonstrates... | Download Scientific Diagram

The diagnostic algorithm in female patients with CK7+/CK20− CUPs. |  Download Scientific Diagram
The diagnostic algorithm in female patients with CK7+/CK20− CUPs. | Download Scientific Diagram

Pathology Outlines - Cytokeratin 7 (CK7, K7)
Pathology Outlines - Cytokeratin 7 (CK7, K7)

Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers:  Clinicopathological features and prognostic significance | BMC Cancer |  Full Text
Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance | BMC Cancer | Full Text

Diagnostic strategies for unknown primary cancer - Varadhachary - 2004 -  Cancer - Wiley Online Library
Diagnostic strategies for unknown primary cancer - Varadhachary - 2004 - Cancer - Wiley Online Library

Differential expression of CK7, CK20, CDX2 in intestinal and  pancreatobiliary types of preriampullary carcinoma
Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma

Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic  Carcinomas of Unknown Primary Site
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site

A combination of the immunohistochemical markers CK7 and SATB2 is highly  sensitive and specific for distinguishing primary ovarian mucinous tumors  from colorectal and appendiceal metastases - ScienceDirect
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - ScienceDirect

March 2012 Residency Program Case of the Month | Department of Pathology UC  Davis Health System
March 2012 Residency Program Case of the Month | Department of Pathology UC Davis Health System

Pathology Outlines - Cytokeratin 7 (CK7, K7)
Pathology Outlines - Cytokeratin 7 (CK7, K7)

CDH17 – Improved sensitivity & specifi city for identifi cation of colon  and stomach adenocarcinomas - Biocare Medical
CDH17 – Improved sensitivity & specifi city for identifi cation of colon and stomach adenocarcinomas - Biocare Medical

CK7 expression associates with the location, differentiation, lymph node  metastasis, and the Dukes' stage of primary colorectal cancers
CK7 expression associates with the location, differentiation, lymph node metastasis, and the Dukes' stage of primary colorectal cancers

The diagnostic algorithm for workup of a CK7−/CK20+ carcinoma. | Download  Scientific Diagram
The diagnostic algorithm for workup of a CK7−/CK20+ carcinoma. | Download Scientific Diagram

Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray  study on 15,424 cancers - ScienceDirect
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers - ScienceDirect

Pembe Oltulu, MD on X: "Ck7(-)\Ck20(-) tumors and follow-up Markers for Ck7(-)\Ck20(-)  tumors #POpath #pathology @JMGardnerMD https://t.co/zgcMh3MKE0" / X
Pembe Oltulu, MD on X: "Ck7(-)\Ck20(-) tumors and follow-up Markers for Ck7(-)\Ck20(-) tumors #POpath #pathology @JMGardnerMD https://t.co/zgcMh3MKE0" / X

CDX2 + CK7 - Biocare Medical
CDX2 + CK7 - Biocare Medical

The diagnostic algorithm for workup of a CK7−/CK20+ carcinoma. | Download  Scientific Diagram
The diagnostic algorithm for workup of a CK7−/CK20+ carcinoma. | Download Scientific Diagram

Cytokeratin 7 expression as a predictor of an unfavorable prognosis in  colorectal carcinoma | Scientific Reports
Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma | Scientific Reports

Immunohistochemical Profile for Unknown Primary Adenocarcinoma | PLOS ONE
Immunohistochemical Profile for Unknown Primary Adenocarcinoma | PLOS ONE

A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63)  allows accurate diagnosis of primary and metastatic lung carcinoma on  biopsy specimens | SpringerLink
A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink